News

July 12, 2017July 12, 2017

Mutations in DNA Repair Genes Linked to Likelihood of Mesothelioma Upon Asbestos Exposure in Study

News

Inherited mutations in the genes responsible for the maintenance and repair of a cell’s DNA can help explain why some people develop malignant pleural mesothelioma (MPM) upon asbestos exposure while others don’t. ... Read more

July 11, 2017July 11, 2017

Measles Virus May Be Ready Weapon to Turn Against Mesothelioma Cells

News

Certain strains of the measles virus could potentially be used to treat mesothelioma because the virus selectively targets a factor found on the surface of mesothelioma cells, researchers from the University of ... Read more

July 10, 2017July 10, 2017

BAP1 Gene Mutations Could Play a Role in Environment-linked Cancers, Studies Suggest

News

Mutations of the BAP1 gene may play a role in the development of cancers like mesothelioma that are also associated with environmental factors, according to two studies. The first article, “BAP1 ... Read more

July 7, 2017

Combination of Immunotoxic Factors and Checkpoint Blocker Clears Mesothelioma in Mice, Study Reports

News

Combining mesothelioma-targeted therapies with one that prevents tumors from evading the immune system led to the eradication of mesothelioma in most mice involved in a study, researchers said. The mesothelioma-specific ... Read more

July 6, 2017July 6, 2017

Researchers Identify Anti-Tumor Effects of Apigenin in Malignant Mesothelioma

News

The anti-tumor effects of apigenin, a molecule that has been shown to inhibit the growth of a variety of human cancers, have been evaluated for the first time in malignant mesothelioma ... Read more

July 5, 2017July 5, 2017

First MPM Patient Dosed in Keytruda, CRS-207 Combo Phase 2 Trial, Aduro Says

News

Aduro Biotech has tested a novel combination treatment for malignant pleural mesothelioma (MPM) in the first patient of a Phase 2 trial (NCT03175172). MPM is the most prevalent form of ... Read more

June 30, 2017

Exposure to Cosmetic Talc Not a Risk Factor for Pleural Mesothelioma, Study Finds

News

A review of studies including workers of the talc industry and patients exposed to cosmetic talc showed that none of those studied developed mesothelioma, disproving reports that asbestos was present ... Read more

June 29, 2017

BAP1 Gene Mutation Helps to Assess Some Tumors, But Not Mesothelioma

News

A new study suggests that mutations in the BAP1 gene, a tumor suppressor that has been implicated in tumor development in several different types of cancer, may improve clinical stratification ... Read more

June 28, 2017

Cell Medica to Manufacture WT1-TCR Therapy for Mesothelioma, Other Solid Tumors in 2018

News

Cell Medica will begin manufacturing WT1-TCR cell therapy for solid tumors that have been difficult to treat with conventional therapies, such as mesothelioma and ovarian cancer. Cell Medica is planning to initiate ... Read more

June 27, 2017June 27, 2017

Assessing Chemo and Immunotherapy Biomarkers at the Right Time Seen as Crucial in Mesotheliomia Monitoring

News

The point at which doctors assess biomarkers of mesothelioma patients’ response to a combination of chemotherapy and immunotherapy is crucial to obtaining a clear picture of how the patients are doing, ... Read more